Target intelligence / Profile preview

Agkistrodon acutus venom thrombin-like enzymes and antithrombin factors (AaV-TLE/AF)

Target
AaV-TLE/AF
Molecular classification
Serine protease, C-type lectin-like protein, Enzyme, Coagulation factor inhibitor
01

Overview

Agkistrodon acutus venom thrombin-like enzymes (TLEs) and antithrombin factors represent a complex group of proteins found in the venom of the sharp-nosed pit viper, a medically significant snake in East Asia [4]. TLEs, such as acutin and acutobin, are serine proteases that functionally mimic human thrombin by cleaving fibrinogen into fibrin; however, they typically do not activate Factor XIII, resulting in the formation of unstable, easily degraded fibrin polymers and subsequent systemic defibrinogenation [1][2]. Antithrombin factors, often belonging to the C-type lectin-like protein family, further disrupt hemostasis by directly binding to and inhibiting thrombin or other critical coagulation factors like Factor X [3]. Clinically, these proteins are the primary targets for neutralization by specific antivenoms during the management of snakebite envenomation, which is characterized by severe coagulopathy and hemorrhage [4]. Beyond their toxicological role, purified TLEs from this species have been investigated as therapeutic defibrinogenating agents for treating thrombotic disorders, such as ischemic stroke, by reducing blood viscosity and preventing further clot growth [2]. Monitoring the activity of these components in patients involves measuring coagulation parameters like plasma fibrinogen levels and prothrombin time.

Other names
AcutinAcutobinAaACSharp-nosed pit viper venom thrombin-like enzymeAgkistrodon acutus anticoagulant factorHundred-pacer venom proteases
02

Mechanism of action

Thrombin-like enzymes (TLEs) catalyze the release of fibrinopeptides from fibrinogen to form unstable fibrin clots, leading to consumptive defibrinogenation [1][2]. Antithrombin factors bind to and inhibit the activity of thrombin or other coagulation factors, preventing the conversion of fibrinogen to fibrin [3].

03

Biological functions

FibrinogenolysisAnticoagulationProteolysisHemostasis modulation
04

Disease associations

Snakebite envenomationThrombosisIschemic strokeCoagulopathy
05

Safety considerations

Severe systemic hemorrhageHypofibrinogenemiaAnaphylaxis to antivenomConsumptive coagulopathy
06

Interacting drugs

Agkistrodon acutus antivenom

4 more in the full profile.

07

Biomarkers

Plasma fibrinogen levelProthrombin time (PT)Activated partial thromboplastin time (aPTT)D-dimerFibrin degradation products (FDPs)

Beyond the preview

Go deeper on Agkistrodon acutus venom thrombin-like enzymes and antithrombin factors (AaV-TLE/AF).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Agkistrodon acutus venom thrombin-like enzymes and antithrombin factors (AaV-TLE/AF).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call